Download Nadia Smati - Osteogenesis

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Promoter (genetics) wikipedia , lookup

Community fingerprinting wikipedia , lookup

RNA-Seq wikipedia , lookup

Silencer (genetics) wikipedia , lookup

Genome evolution wikipedia , lookup

Gene expression profiling wikipedia , lookup

Mutation wikipedia , lookup

Artificial gene synthesis wikipedia , lookup

Molecular evolution wikipedia , lookup

Transcript
Osteogenesis
Imperfecta
Nadia Smati
Genomics and Medicine
The Brittle Bone Disease
“Imperfect Bone Formation”
Congenital
Caused by various gene mutations that affect Collagen
-Type 1 Collagen Critical Bone Structure
-Severity of defect impacts severity of OI
8 Different types- various characteristics/mutations/consequences
Affects 6-7/100,000 People World Wide (I and IV most common)
4 Genes
COL1A1,COL1A2, CTRAP, AND LEPRE1
COL1A1/COL1A2
-Cause more than 90% of OI cases
-Types I,II,III,and IV
-Similar function- produce Type I collagen
-Different Chromosome Locations/Severity
-Type I- Premature termination of codons
-Type II,III,IV-Amino Acid Substitution of Glycine
-Functional Consequence: Deficiency of Collagen/Fail to Produce Enough
CTRAP/LEPRE1
-Rare, severe cases (although II is the most severe type)
-Functional Consequence: Disrupt production of Collagen Molecules themselves
-CTRAP-TypeVI /LEPRE1-Type VIII
*NOT all genes known- still cases found without an identified mutation in any of the 4 genes
Inheritance
Variance
Most common: Autosomal Dominant
Some cases (type VII) found to be Autosmal
Recessive
35% Cases found to be De Nova Mutation
Full Penetrance for Autosmal Dominant
Types of OI
Key Distinguishing FactorsCollagen Quality and Quantity based on mutation
Genetic Differences/Mutations used to Classify Types
(COL1A1/COL1A2)
I-Sufficient Quality/Insufficient Quantity (*Most Common)
II-Insufficient Quality/Insufficient Quality
III-Insufficient Quality (poor formation)/Sufficient Quantity
IV-Insufficient Quality/Sufficient Quantity
V/VI-Very similar to IV with different histologic features
Thus: Type I most mild OI//Type II most severe OI
Rest of Types fall between
VII/VIII
-Very rare
-Autosomal Recessive
Prognosis
Depends on type of OI:
Type I - normal lifespan.
Type II - death in the first year of life.
Type III-wheelchair bound and usually have a shortened life expectancy.
Type IV- often need braces or crutches to walk. Life expectancy normal or near normal.
Characteristic Symptoms
Symptoms Vary According to OI Type:
-Bone fractures in childhood/adolescence from Mild trauma
-Fractures before birth or little/no trauma
-Blue Sclerae
-Kyphoscoliosis
-Short Stature
-Respiratory Problems
-Ribcage fragile/deformed-infants have trouble breathing and die
almost immediately
-Hearing loss
-Dentinogenesis Imperfecta
Diagnostics
Classical:
X Rays can reveal fractures and bone deformities to confirm symptoms
Novel:
Collagen analysis from skin biopsy to check for types/quantities collagen present
Gene/DNA analysis to examine characteristic mutant genes
DNA sequencing can now find close to 100% of mutations in COL1A1 and COL1A2
genes
Treatments
Currently No Cure
Classical:
Essentially Treatment of Manifestations/Symptoms
Therapy,Physical Medicine, Orthopedic, Surveillance (children), Dental
Novel:
Gene Therapy difficult because of many gene variations
Bisphosphonates to prevent loss of bone mass (under evaluation)
Injection of Human Growth Hormone (under evaluation)
Bone Marrow Transplant (under evaluation)
History
Recognized in Egyptian Mummy from 1000 BC
Most Notable Case- Ivan the Boneless, Prince of 9th Century Denmark
Carried on shield to battle because unable to walk on “soft legs”
Nabil Shaban, actor- documentary: The Strangest Viking
1918 Dr. Van der Hoeve described fragile bones, blue sclera,and deafness as distinct inherited syndrome
1970’s Dr. David Sillence developed “Types” Categorization combining clinical symptoms with genetic components